Jump to content
RemedySpot.com

FDA approves new HIV, hepatitis screen

Rate this topic


Guest guest

Recommended Posts

http://www.upi.com/Health_News/2008/12/30/FDA_approves_new_HIV_hepatitis_screen/\

UPI-31351230695659/

FDA approves new HIV, hepatitis screen

Published: Dec. 30, 2008 at 10:54

PLEASANTON, Calif., Dec. 30 (UPI) -- The U.S. government Tuesday approved a

nucleic acid test that screens for less common forms of HIV that recently have

appeared in the United States.

The U.S. Food & Drug Administration approved the test from the Swiss firm Roche

Diagnostics to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and

hepatitis B DNA.

The test, called the cobas TaqScreen MPX Test for use on the cobas s 201 system,

is a qualitative test for human plasma. The test, which is not intended for use

as an aid in diagnosis, is designed to further increase the safety of blood

supplies by identifying infections earlier than traditional serology tests --

identification of antibodies in the blood, statement from the drug company said.

" Roche is committed to meeting the needs of blood centers with tests and systems

that ensure the highest blood safety, " O'Day, head of Roche Molecular

Diagnostics, the business area of Roche Diagnostics that developed the test,

said in a statement.

" Our multiplex test has been widely adopted and has demonstrated excellent

performance in blood centers worldwide. "

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...